UNH Earnings

UNH reported its FY2025Q4 earnings on 2026-01-27, showcasing a revenue of 113.00B against an estimate of 114.00B, resulting in a -0.37% surprise. The EPS was 2.11, surpassing the expected 2.09 by 0.96% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following UNH's FY2025Q4 earnings announcement on 2026-01-27, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, UNH's stock price tends to shift by an average of +0.00% in the 10 days leading up to earnings and +0.00% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate UNH’s annual revenue to reach 114.00B, while the EPS is projected at 7.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.06% and EPS estimates Revise Downward by -0.27% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between UNH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -0.06%, while EPS estimates moved Revise Downward by -0.27% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, UNH's stock price typically moves by +0.00% in the 10 days before its earnings and +0.00% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 7.00 and revenue of 114.00B.

The earnings call reflects a mixed outlook with concerns about margin recovery and membership contraction in key segments like Medicare Advantage and Medicaid. Despite some positive elements like operational improvements and strategic clarity, uncertainties remain, particularly regarding 2027 guidance and the impact of rate reductions. The Q&A highlighted management's cautious approach, avoiding specific future estimates, which adds to investor uncertainty. While some positive catalysts exist, such as value-based care and AI-driven productivity, the overall sentiment is balanced by potential challenges, leading to a neutral stock price prediction.